New API Firm Established In Middle East

Indian drugmaker Dishman Pharmaceuticals and Chemicals has entered into a joint venture with three other regional partners to manufacture active pharmaceutical ingredients (APIs) in Saudi Arabia. The new production facility is expected to be fully operational in 15 months. We believe that generic drugmakers in Saudi Arabia will be well positioned to boost output and reduce the traditional reliance on imported

To read the full article, please sign in or take a free trial.